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The mechanisms by which carbon tetrachloride (CC14) and other 
poisons produce their deleterious effects upon the liver have been recently 
reexamined. The impetus for the current interest in this problem arose 
from the studies of Christie and Judah1 and Dianzani.2 These investi­
gators presented evidence showing that CC14 was capable of directly af­
fecting mitochondrial oxidative enzymes of the liver parenchymal cell 
and postulated that the primary defect was probably the result of the 
release of coenzyme from the mitochondria. That these changes can 
be brought about in vitro and in vivo has been confirmed by many 
groups.3·4·6 ' 6 
From a consideration of the vigorous treatment necessary to produce 
these changes in vitro and from evidence which appeared in the literature 
relating to the sympathetic nature of fat depot innervation, we began a 
series of experiments which led to the hypothesis set forth in 1959 that 
CCI4 effects on the liver are largely indirect.7· 8 The hypothesis that the 
sympathetic nervous system played a major role in CCl4-induced hepato-
toxicity stemmed from the following observations: 
1. I t was shown that the effects of CC14 on the liver, both the centri-
lobular necrosis and the lipid accumulation could be markedly reduced 
by prior administration of adrenergic blocking agents such as dibenzyline, 
ergotamine, and phentolamine.7 The effect on necrosis was more pro­
nounced than the protection against lipid accumulation. 
2. Prior high spinal transection in the rat could block completely both 
of these changes produced by CCI4.7·9·10 Liver damage was assessed both 
by changes in mitochondrial function (such as the loss in diphospho-
pyridine nucleotide-linked oxidative enzyme function or the ATP-ase 
transformation5), and by histological examination. Lipid accumulation 
was determined by measuring both total lipids9 and triglycérides. 
3. I t was also demonstrated that the catecholamine content of the 
adrenal medulla of the CCl4-treated rat was reduced. Furthermore, 
prior cord section which protected the liver also prevented this loss of 
epinephrine and norepinephrine from the adrenal.712 
Another early observation supported the concept that the centrilobular 
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changes and the lipid accumulation were separable phenomena. Reck-
nagel et al.11 had reported that the lipid rise was an early effect, while the 
mitochondrial changes were a later manifestation of liver damage. Studies 
in adrenalectomized animals tended to confirm this concept.7· 9 Adrenal-
ectomy only minimally modified the mitochondrial changes and necrosis 
seen after CCI4, yet no lipid accumulation was evident either by chemical 
measurement or histological examination. 
The studies to be presented here are offered as further evidence that 
the action of carbon tetrachloride upon the liver in vivo is primarily an 
indirect one and also supports our hypothesis that the sympathetic nervous 
system plays a key role in the toxicity. 
Results 
A. Ganglionic blockade. Since we were able to effectively protect 
against the liver damage by prior spinal transection, ganglionic blockade 
was selected as a means of blocking nervous transmission to determine 
whether such a pharmacologie agent might protect as effectively. A 
relatively long-acting ganglion-blocking agent was selected, trimethidium 
bismethosulfate (Ostensin, Wyeth). A long-acting compound was deemed 
necessary since CCl4-treated animals were usually sacrificed 20 hours 
after a single administration of the poison and such a drug would avoid 
multiple injections in order to maintain good blockade. The protective 
effects of ganglionic blockade on liver mitochondria from CCl4-treated 
rats are illustrated in TABLE 1. Also for comparative purposes is shown 
a typical experiment where the same parameters were measured in a cord-
sectioned rat receiving CCI4. 
This data would indicate that as far as CCU-induced damage in mito­
chondrial activity is concerned, prior administration of this ganglionic 
blocking agent was apparently almost as effective as prior spinal tran­
section. Ganglionic blockade was also equally effective in preventing 
the ATP-ase transformation. However, this agent did not markedly 
reduce the lipid accumulation usually observed with CC14.13 FIGURE 3 
shows a section of rat liver from an animal receiving trimethidinium and 
then challenged with the standard dose of CC14 (2.5 ml./kg., orally in 
peanut oil). FIGURE 1 shows a section of a liver from a rat receiving only 
CCI4. It can be seen that ganglionic blockade affords excellent protection, 
but not as effective as that seen with prior cord section shown in FIGURE 2, 
the latter tissue being indistinguishable from that obtained from the liver 
of an untreated control. While no centrilobular changes are seen with 
this ganglionic blocking agent, there is still marked triglycéride accumula­
tion (FIGURE 3). FIGURE 4 shows (for comparative purposes) the liver 
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TABLE 1 
EFFECTS OF GANGLIONIC BLOCKADE AND CORD-SECTION ON 
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*Microatoms oxygen consumed in 7 minutes. 
fRatio of micromoles of inorganic phosphate taken up to microatoms of oxygen 
consumed. 
ÎTrimethidinum bismethosulfate, 50 mgm./kgm. S.Q., in two doses, 2 hours prior to 
and 10 hours after CC14. 
from an animal receiving CC14 after adrenalectomy. Here, it is clear that 
necrotic changes have occurred, yet there is no apparent accumulation of 
fat. This has been confirmed by chemical analysis. I t should be pointed 
out that Rees14 has found that prior adrenalectomy fails to protect against 
this increase in lipids. 
B. Anti-release agents. The effects of a number of so-called sympa­
thetic anti-release agents were also investigated. These compounds, while 
F I G U R E 1. Liver from rat receiving 2.5 ml./kg. of CC14 orally 20 hours prior to 
sacrifice. H & E stain. X 100. 
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FIGURE 2. Liver from cord-sectioned rat receiving the standard dose of CCI4 20 
hours prior to sacrifice. H & E stain. X 100. 
FIGURE 3. Liver from a rat after ganglionic blockade and CCI4. H & E stain. 
X 100. 
FIGURE 4. Liver from a CCl4-treated rat after prior adrenalectomy. H & E stain. 
X 100. 
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they may possess other pharmacologie properties as well, are all capable of 
preventing norepinephrine secretion from sympathetic post-ganglionic 
fibers. The drugs studied included /3-TM-10, (2-2,6-dimethylphenoxy 
propyl)-trimethyl-ammonium chloride,* guanethidine (Ismelin),t and 
bretylium (Darenthin). TABLE 2 shows the effects of /3-TM-10 on mito-
chondrial oxidative phosphorylation of livers from rats receiving CC14 
after the anti-release drug. This is a typical experiment and illustrates 
TABLE 2 
E F F E C T OF P R I O R ADMINISTRATION OF AN ANTI-RELEASE AGENT ON 
































*Microatoms of oxygen consumed in 7 minutes. 
tRat io of micromoles of inorganic phosphate taken up to microatoms of oxygen con­
sumed. 
that this drug too is capable of protecting against the mitochondrial damage 
seen with CCI4.13 However, prior pretreatment was essential and large 
doses of the drug were necessary. Similar results could be obtained with 
both guanethidine and bretylium, although both of these were somewhat 
less effective than /3-TM-10. 
Histologie sections of livers of animals pretreated with 0-TM-1O and 
guanethidine and challenged with the standard dose of CC14 are shown in 
FIGURES 5 and 6 respectively. ß-TM-10 affords excellent protection 
against centrilobular change, however there is still quite a marked accumu­
lation of lipid (FIGURE 5). Guanethidine (FIGURE 6) was less effective, 
but still gave significant protection. The histologie changes seemed to 
correlate quite well with the biochemical events for this group of com­
pounds. 
C. Catecholamines. While decreased catecholamine levels in adrenals 
of CCl4-treated rats had been previously reported by our group,12 circulat­
ing levels of catecholamines were not determined at that time. Recent 
*SKF 6890A, kindly supplied by E . J . Fellows, Smith, Kline, and French Labs. 
Philadelphia, Pa. 
fKindly supplied by F . F . Yonkman, Ciba Labs., Summit, N. J . 
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FIGURE 6. Liver from a rat 20 hours after receiving CCli and after pretreatment 
with guanethidine. H & E stain. X 100. 
studies have shown that CC14 is capable of elevating both plasma and urine 
epinephrine and norepinephrine levels.15,16 The elevated urinary free 
catecholamine levels were shown to be the result of increased secretion 
rather than decreased metabolism or tissue depletion. It could also be 
shown that agents that were effective in reducing the necrosis usually 
seen with CC14 could also reduce the elevated norepinephrine excretion of 
CCU-treated animals. Some of these data are shown in TABLE 3. 
I t may be observed from TABLE 3 that although these agents are not all 
effective in blocking the CCl4-induced epinephrine increase, they do 
markedly depress the rise in norepinephrine excretion that is usually seen 
with CC14. This increase in excretion of free amine could be detected as 
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TABLE 3 
URINARY EXCRETION OF F R E E CATECHOLAMINES* 
Treatment 
Control 
ecu CCU + Cord section 
CCU + 0-TM-1O 
CCU + Guanethidine 















*Assayed by the procedure of Bertler et al." 
fMicrograms free base/kg./24 hours. 
early as two hours after CC14 treatment and was continuous until the 
animal was sacrificed. 
D. Corticosterone levels after CCU administration. Since CCI4 does 
elevate plasma catecholamines and increase the excretion of free epinephrine 
and norepinephrine, it seemed likely that it might also effect a steroid re­
lease. Plasma corticosterone levels were determined after CC14 ad­
ministration. As shown in TABLE 4, CCI4 does evoke a rise in corticosterone 
levels in rat plasma. While the effect is marked (about 3-4 fold), it is 
not long-lasting. Furthermore, cord-sectioned animals alsojexhibit this 
elevation in steroid levels. Although this confirms the fact that CC14 
TABLE 4 
PLASMA CORTICOSTERONE FOLLOWING C C L 4 ADMINISTRATION 
none 
CCU (1 hr.) 
CCU (2 hr.) 
CCU (5 hr.) 
CCU (10 hr.) 
Peanut oil (1 hr.) 
Peanut oil (2 hr.) 



















20 ± 8 
67 ± 11 
70 ± 7 
64, 59 
42 ± 10 
39 ± 4 
29 ± 7 
3 ,1 
43, 44 
47 ± 10 
*Mean ± s.d. 
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is a stressing agent, it is unlikely that the elevation in steroid observed 
plays a prominent role in CCI4 hepatotoxicity. 
E. Lipid accumulation. The effect of CC14 upon the increase of liver 
triglycéride has been widely studied. A recent report by Recknagel18 
has suggested that liver triglycérides rise because of the failure of a "tri-
glyceride-secreting mechanism" of the hepatic parenchymal cell. Other 
possibilities may be a decrease in synthesis of protein carrier19·20 or an 
increase in the mobilization of free fatty acid from peripheral depots.8· 9 · 2 1 
That epinephrine and norepinephrine are capable of mobilizing depot fat 
is now well-established.22"25 I t is certainly conceivable that several of 
these factors may be important when the ultimate mechanism is established. 
However, since corticoids do influence lipid accumulation (see studies on 
adrenalectomized animals above), and from the evidence that has ac­
cumulated that corticoids play a permissive role in catecholamine action, 
it would be surprising if epinephrine and/or norepinephrine were not in 
some way responsible for the triglycéride accumulation after CCI4 ad­
ministration. 
Summary 
The experiments with the ganglionic blocking compound and the anti-
release agents would tend to support the hypothesis that the sympathetic 
nervous system plays a key role in CCl4-induced hepatotoxicity in the rat. 
Studies on plasma levels and the urinary excretion of free norepinephrine 
are offered as further evidence that hepatic damage is at least in part a 
consequence of sympathetic stimulation. While corticosterone is also 
elevated by CCI4, its role in liver necrosis appears to be a minor one. 
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